mTOR inhibition improves antitumor effects of vaccination with antigen-encoding RNA

Cancer immunology research

Volumn 1, Issue 6, 2013, Pages 386-392

  Diken, Mustafa ^a   Kreiter, Sebastian ^a   Vascotto, Fulvia ^a   Selmi, Abderraouf ^a   Attig, Sebastian ^a   Diekmann, Jan ^a   Huber, Christoph ^a   Türeci, Özlem ^a   Sahin, Ugur ^a  

^a Ganymed Pharmaceuticals   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; CANCER VACCINE; MTOR PROTEIN, MOUSE; RAPAMYCIN; RECOMBINANT VACCINE; RNA; TARGET OF RAPAMYCIN KINASE; TUMOR ANTIGEN;

ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DRUG EFFECTS; DRUG SCREENING; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MELANOMA, EXPERIMENTAL; MULTIMODALITY CANCER THERAPY; PROCEDURES; TUMOR ASSOCIATED LEUKOCYTE; VACCINATION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; COMBINED MODALITY THERAPY; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; IMMUNOLOGIC MEMORY; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA, EXPERIMENTAL; MICE, INBRED C57BL; RNA, NEOPLASM; SIROLIMUS; TOR SERINE-THREONINE KINASES; VACCINATION; VACCINES, SYNTHETIC;

EID: 84919872967     PISSN: None     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-13-0046     Document Type: Article

References (0)